EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comprehensive genomic profiling of triple-negative breast cancer metastases identifies role of PKD1 in immunotherapy resistance

Xiu-Zhi Zhu, Yi-Fan Zhou, Xiao-Han Ying, Yun-Yi Wang, Xiao-Hong Ding, Kun-Yu Zhang, Zhi-Ming Shao, Xi Jin, Yi-Zhou Jiang, Zhong-Hua Wang

Journal of Clinical Investigation · 02.03.2026 · 136 (5)

DOI: 10.1172/jci188989 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 02.03.2026. Verfasst von Xiu-Zhi Zhu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Immunotherapy, Mutation, Neoplasm Proteins. Die Arbeit nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, the Program of Shanghai Academic/Technology Research Leader, Shanghai Anti-Cancer Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, NeoplasmImmunotherapyMutationNeoplasm ProteinsTriple Negative Breast NeoplasmsTRPP Cation ChannelsAnimalsFemaleHumansMiceChemokine CCL2Neoplasm MetastasisTumor MicroenvironmentClinical Trials, Phase I as TopicClinical Trials, Phase II as TopicRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

Breast cancerGeneticsImmunotherapyOncology

Substanzen

CCL2 protein, humanChemokine CCL2Neoplasm ProteinsTRPP Cation Channels

Autor:innen und Institutionen

  • Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Key Laboratory of Breast Cancer in Shanghai, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.

Förderung

  • National Natural Science Foundation of China
  • the Program of Shanghai Academic/Technology Research Leader
  • Shanghai Anti-Cancer Association
  • The Foundation of the Shanghai Municipal Education Commission
  • National Natural Science Foundation of Shanghai

Zitieren

APA

Zhu, X. Z., Zhou, Y. F., Ying, X. H., Wang, Y. Y., Ding, X. H., Zhang, K. Y., Shao, Z. M., Jin, X., Jiang, Y. Z., & Wang, Z. H. (2026). Comprehensive genomic profiling of triple-negative breast cancer metastases identifies role of PKD1 in immunotherapy resistance. Journal of Clinical Investigation, 136(5). https://doi.org/10.1172/jci188989

Vancouver

Zhu XZ, Zhou YF, Ying XH, Wang YY, Ding XH, Zhang KY, et al. Comprehensive genomic profiling of triple-negative breast cancer metastases identifies role of PKD1 in immunotherapy resistance. Journal of Clinical Investigation. 2026;136(5). doi:10.1172/jci188989

BibTeX
@article{Zhu2026,
  author = {Zhu, Xiu-Zhi and Zhou, Yi-Fan and Ying, Xiao-Han and Wang, Yun-Yi and Ding, Xiao-Hong and Zhang, Kun-Yu and Shao, Zhi-Ming and Jin, Xi and Jiang, Yi-Zhou and Wang, Zhong-Hua},
  title = {Comprehensive genomic profiling of triple-negative breast cancer metastases identifies role of PKD1 in immunotherapy resistance},
  journal = {Journal of Clinical Investigation},
  year = {2026},
  volume = {136},
  number = {5},
  doi = {10.1172/jci188989}
}
Kostenlos starten →